Review

From Synaptic Dysfunction to Memory Recovery: Ampakine Compounds as Potential Therapeutic Agents for Alzheimer's Disease

Volume: 1 Number: 3 December 31, 2023
EN

From Synaptic Dysfunction to Memory Recovery: Ampakine Compounds as Potential Therapeutic Agents for Alzheimer's Disease

Abstract

Alzheimer's disease, a profoundly impactful neurodegenerative condition, manifests as the progressive deterioration of memory and cognitive functions. Studies have shown that memory decline is associated with a decrease in the rapid transmission of excitatory signals between neurons. The limited research on the positive impact of AMPA receptor modulation has prompted the exploration of Ampakine compounds. Ampakines enhance long-term potentiation (LTP) by activating receptors, which exists in a crucial role in memory preservation. The ability of ampakine compounds to bind to AMPA receptors and increase the expression of neurotrophic factors, such as BDNF, is believed to mitigate LTP impairment. Recent studies have demonstrated that certain ampakine compounds can enhance consciousness and memory storage by promoting the production of various neurotrophins, particularly BDNF and NGF. Previous research has shown that neurotrophins contribute to synaptogenesis, the formation of new connections between neurons, primarily through dendritic spines. Increasing synaptogenesis via dendritic spines positively impacts signal transmission and retention by strengthening neuronal connections. This review highlights the potential of ampakine compounds such as pesampator and hydroflumetazide to enhance synaptic interactions, alleviate symptoms of Alzheimer's disease, and specifically address memory loss through their effects on neurotrophins.

Keywords

Project Number

TDK-2022-11285

References

  1. Ackermann, M., & Matus, A. (2003). Activity-induced targeting of profilin and stabilization of dendritic spine morphology.Natureneuroscience,6(11),1194-1200. https://doi.org/10.1038/nn1135
  2. Aoki, C., Wu, K., Elste, A., Len, G. W., Lin, S. Y., McAuliffe, G., & Black, I. B. (2000). Localization of brain‐derived neurotrophic factor and TrkB receptors to postsynaptic densities of adult rat cerebral cortex. Journal of neuroscience research, 59(3), 454-463. https://doi.org/10.1002/(SICI)1097-4547(20000201)59:3%3C454::AID-JNR21%3E3.0.CO;2-H
  3. Araya, R., Eisenthal, K. B., & Yuste, R. (2006).Dendritic spines linearize the summation of excitatory potentials. Proceedings of the National Academy of Sciences,103(49),18799-18804. https://doi.org/10.1073/pnas.0609225103
  4. Bliss, T.V, and Collingridge, G.L. (1993). A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31–39.
  5. Blum, R., & Konnerth, A. (2005). Neurotrophin-mediated rapid signaling in the central nervous system: mechanisms and functions. Physiology, 20(1),70-78. https://doi.org/10.1152/physiol.00042.2004
  6. Bourne, J., & Harris, K. M. (2007). Do thin spines learn to be mushroom spines that remember?. Current opinion in neurobiology,17(3),381-386. https://doi.org/10.1016/j.conb.2007.04.009
  7. Bramham, C. R. (2008). Local protein synthesis, actin dynamics, and LTP consolidation. Current opinion in neurobiology,18(5),524-531. https://doi.org/10.1016/j.conb.2008.09.013
  8. Brogi, S., Campiani, G., Brindisi, M., & Butini, S. (2019). Allosteric modulation of ionotropic glutamate receptors: An outlook on new therapeutic approaches to treat central nervous system disorders. ACS Medicinal Chemistry Letters,10(3),228-236. https://doi.org/10.1021/acsmedchemlett.8b00450

Details

Primary Language

English

Subjects

Pharmaceutical Sciences

Journal Section

Review

Early Pub Date

December 29, 2023

Publication Date

December 31, 2023

Submission Date

November 9, 2023

Acceptance Date

December 28, 2023

Published in Issue

Year 2023 Volume: 1 Number: 3

APA
Özten, Ö. (2023). From Synaptic Dysfunction to Memory Recovery: Ampakine Compounds as Potential Therapeutic Agents for Alzheimer’s Disease. Recent Trends in Pharmacology, 1(3), 167-191. https://izlik.org/JA77RL95ZD
AMA
1.Özten Ö. From Synaptic Dysfunction to Memory Recovery: Ampakine Compounds as Potential Therapeutic Agents for Alzheimer’s Disease. Recent Trends in Pharmacology. 2023;1(3):167-191. https://izlik.org/JA77RL95ZD
Chicago
Özten, Ömer. 2023. “From Synaptic Dysfunction to Memory Recovery: Ampakine Compounds As Potential Therapeutic Agents for Alzheimer’s Disease”. Recent Trends in Pharmacology 1 (3): 167-91. https://izlik.org/JA77RL95ZD.
EndNote
Özten Ö (December 1, 2023) From Synaptic Dysfunction to Memory Recovery: Ampakine Compounds as Potential Therapeutic Agents for Alzheimer’s Disease. Recent Trends in Pharmacology 1 3 167–191.
IEEE
[1]Ö. Özten, “From Synaptic Dysfunction to Memory Recovery: Ampakine Compounds as Potential Therapeutic Agents for Alzheimer’s Disease”, Recent Trends in Pharmacology, vol. 1, no. 3, pp. 167–191, Dec. 2023, [Online]. Available: https://izlik.org/JA77RL95ZD
ISNAD
Özten, Ömer. “From Synaptic Dysfunction to Memory Recovery: Ampakine Compounds As Potential Therapeutic Agents for Alzheimer’s Disease”. Recent Trends in Pharmacology 1/3 (December 1, 2023): 167-191. https://izlik.org/JA77RL95ZD.
JAMA
1.Özten Ö. From Synaptic Dysfunction to Memory Recovery: Ampakine Compounds as Potential Therapeutic Agents for Alzheimer’s Disease. Recent Trends in Pharmacology. 2023;1:167–191.
MLA
Özten, Ömer. “From Synaptic Dysfunction to Memory Recovery: Ampakine Compounds As Potential Therapeutic Agents for Alzheimer’s Disease”. Recent Trends in Pharmacology, vol. 1, no. 3, Dec. 2023, pp. 167-91, https://izlik.org/JA77RL95ZD.
Vancouver
1.Ömer Özten. From Synaptic Dysfunction to Memory Recovery: Ampakine Compounds as Potential Therapeutic Agents for Alzheimer’s Disease. Recent Trends in Pharmacology [Internet]. 2023 Dec. 1;1(3):167-91. Available from: https://izlik.org/JA77RL95ZD